| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
41,745 |
34,674 |
$2.16M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
25,395 |
21,995 |
$42K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,800 |
3,592 |
$15K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,185 |
3,151 |
$14K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
3,988 |
3,947 |
$8K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,162 |
2,156 |
$6K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,669 |
1,657 |
$4K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,496 |
1,438 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
384 |
371 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,575 |
1,506 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,254 |
4,083 |
$2K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,149 |
1,116 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,875 |
1,819 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,229 |
839 |
$937.27 |
| 90677 |
|
361 |
361 |
$866.05 |
| 90651 |
|
374 |
373 |
$401.42 |
| 87807 |
|
272 |
260 |
$308.61 |
| 87428 |
|
277 |
275 |
$237.54 |
| 90474 |
|
441 |
433 |
$159.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
89 |
79 |
$86.56 |
| 85018 |
|
155 |
150 |
$47.14 |
| 99441 |
|
35 |
33 |
$29.32 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
36 |
36 |
$18.40 |
| 81002 |
|
132 |
128 |
$14.82 |
| 90647 |
|
1,660 |
1,636 |
$0.04 |
| 90723 |
|
1,648 |
1,629 |
$0.00 |
| 90686 |
|
1,105 |
1,089 |
$0.00 |
| 90680 |
|
1,446 |
1,429 |
$0.00 |
| 90716 |
|
119 |
119 |
$0.00 |
| 90696 |
|
149 |
147 |
$0.00 |
| 90656 |
|
82 |
82 |
$0.00 |
| 99381 |
|
12 |
12 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
17 |
14 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
26 |
26 |
$0.00 |
| 96127 |
|
12 |
12 |
$0.00 |
| 36416 |
|
26 |
26 |
$0.00 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
139 |
124 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
12 |
12 |
$0.00 |
| 90670 |
|
1,853 |
1,828 |
$0.00 |
| 90461 |
|
13 |
13 |
$0.00 |
| 90707 |
|
104 |
104 |
$0.00 |
| 90734 |
|
370 |
367 |
$0.00 |
| 90633 |
|
769 |
760 |
$0.00 |
| 90710 |
|
152 |
151 |
$0.00 |
| 90700 |
|
141 |
141 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
13 |
13 |
$0.00 |
| 90685 |
|
34 |
33 |
$0.00 |
| 90715 |
|
120 |
118 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
36 |
34 |
$0.00 |